These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4899771)

  • 1. Adverse effect on bacteria of peritoneal dialysis solutions that contain acetate.
    Richardson JA; Borchardt KA
    Br Med J; 1969 Sep; 3(5673):749-50. PubMed ID: 4899771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma and the antibacterial effect of peritoneal dialysis solutions.
    Borchardt KA; Richardson JA
    Br Med J; 1971 Jan; 1(5742):205-6. PubMed ID: 5541232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetate versus lactate in peritoneal dialysis solutions.
    Pedersen FB; Ryttov N; Deleuran P; Dragsholt C; Kildeberg P
    Nephron; 1985; 39(1):55-8. PubMed ID: 3969192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
    Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
    Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net ultrafiltration volume (nUFV) during IPD with acetate or lactate dialysis solutions.
    Grzegorzewska AE; Uchman G
    Adv Perit Dial; 1990; 6():19-22. PubMed ID: 1982806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].
    Soria M; Arrieta J; Ugarte I; Moina I; Guerra M; Escanero J
    Nefrologia; 2004; 24(2):158-66. PubMed ID: 15219091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effects of acetate and lactate in peritoneal dialysis solutions.
    Rossen B; Ladefoged J
    Scand J Urol Nephrol; 1982; 16(3):279-81. PubMed ID: 7163792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis.
    Miller FN; Nolph KD; Joshua IG; Wiegman DL; Harris PD; Andersen DB
    Kidney Int; 1981 Sep; 20(3):397-402. PubMed ID: 7300129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium acetate as a preservative in protein hydrolysate solutions.
    Frech G; Allen LV; Stiles ML; Levinson RS
    Am J Hosp Pharm; 1979 Dec; 36(12):1672-5. PubMed ID: 118672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological studies on lomefloxacin--a new quinolone.
    Newsom SW; Rowland C
    J Chemother; 1989 Jul; 1(4 Suppl):168-9. PubMed ID: 16312354
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate?
    Binswanger U; Keusch G; Bammatter F; Heule H; Kiss D
    Nephron; 1981; 28(6):300-2. PubMed ID: 7312085
    [No Abstract]   [Full Text] [Related]  

  • 13. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability of 8 second or third generation cephalosporins in peritoneal dialysis fluid].
    Grise G; Lemeland JF; Fillastre JP
    Pathol Biol (Paris); 1985 May; 33(5):335-9. PubMed ID: 3897963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lactate and acetate determination in infusions or dialysis solutions using high pressure liquid chromatography].
    Bichsel S
    Pharm Acta Helv; 1984; 59(2):62-4. PubMed ID: 6709666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Causative agents in infections of the hand and their sensitivity for antibiotics].
    Schmauss AK; Stimmel F; Perlin L
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):141-4. PubMed ID: 4930187
    [No Abstract]   [Full Text] [Related]  

  • 17. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal inhibitory concentration of natural vinegar and of aluminium acetate-tartrate solution.
    Lang U
    Otol Neurotol; 2013 Jul; 34(5):795-7. PubMed ID: 23739558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis solutions.
    Gault MH
    Can Med Assoc J; 1973 Feb; 108(3):325-7. PubMed ID: 4691094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetate dialysate: responsible for decrease in ultrafiltration in continuous ambulatory peritoneal dialysis].
    Faller B; Marichal JF
    Nephrologie; 1984; 5(2):71-6. PubMed ID: 6483075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.